Literature DB >> 24787977

The other face of chimeric antigen receptors.

Gianpietro Dotti1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24787977      PMCID： PMC4015232          DOI： 10.1038/mt.2014.58

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

1.  Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

Authors:  Dan Blat; Ehud Zigmond; Zoya Alteber; Tova Waks; Zelig Eshhar
Journal:  Mol Ther       Date:  2014-03-06       Impact factor: 11.454

2.  Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.

Authors:  John Maher; Renier J Brentjens; Gertrude Gunset; Isabelle Rivière; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

3.  Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product.

Authors:  H M Finney; A D Lawson; C R Bebbington; A N Weir
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

Review 4.  The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

Authors:  S Hammarström
Journal:  Semin Cancer Biol       Date:  1999-04       Impact factor: 15.707

5.  T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

Authors:  Maria R Parkhurst; James C Yang; Russell C Langan; Mark E Dudley; Debbie-Ann N Nathan; Steven A Feldman; Jeremy L Davis; Richard A Morgan; Maria J Merino; Richard M Sherry; Marybeth S Hughes; Udai S Kammula; Giao Q Phan; Ramona M Lim; Stephen A Wank; Nicholas P Restifo; Paul F Robbins; Carolyn M Laurencot; Steven A Rosenberg
Journal:  Mol Ther       Date:  2010-12-14       Impact factor: 11.454

6.  Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis.

Authors:  J E Smithson; B F Warren; S Young; R Pigott; D P Jewell
Journal:  J Pathol       Date:  1996-10       Impact factor: 7.996

7.  Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Authors:  G Gross; T Waks; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  CD28 costimulation is essential for human T regulatory expansion and function.

Authors:  Tatiana N Golovina; Tatiana Mikheeva; Megan M Suhoski; Nicole A Aqui; Victoria C Tai; Xiaochuan Shan; Ronghua Liu; R Robert Balcarcel; Nancy Fisher; Bruce L Levine; Richard G Carroll; Noel Warner; Bruce R Blazar; Carl H June; James L Riley
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 9.  Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

Authors:  Maria-Grazia Roncarolo; Manuela Battaglia
Journal:  Nat Rev Immunol       Date:  2007-08       Impact factor: 53.106

10.  Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.

Authors:  Manuela Battaglia; Angela Stabilini; Barbara Migliavacca; Jutta Horejs-Hoeck; Thomas Kaupper; Maria-Grazia Roncarolo
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422
View more
  2 in total

Review 1.  Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer.

Authors:  Daniel Sur; Andrei Havasi; Calin Cainap; Gabriel Samasca; Claudia Burz; Ovidiu Balacescu; Iulia Lupan; Diana Deleanu
Journal:  J Clin Med       Date:  2020-01-09       Impact factor: 4.241

Review 2.  Advances and challenges of CAR T therapy and suitability of animal models (Review).

Authors:  Xavier E Ramos-Cardona; Weichuan Luo; Sulma I Mohammed
Journal:  Mol Clin Oncol       Date:  2022-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.